2020-2025 Global Parkinson’s Disease Drugs Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
This report elaborates the market size, market characteristics, and market growth of the Parkinson’s Disease Drugs industry, and breaks down according to the type, application, and consumption area of Parkinson’s Disease Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Parkinson’s Disease Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Parkinson’s Disease Drugs market covered in Chapter 13:
UCB S.A
Lundbeck A/S
Orion Pharma
Impax Laboratories, Inc.
Hoffmann-La Roche Ltd
Novartis AG
Pfizer, Inc.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc.
Vertical Pharmaceuticals, LLC
In Chapter 6, on the basis of types, the Parkinson’s Disease Drugs market from 2015 to 2025 is primarily split into:
Decarboxylase Inhibitors
Dopamine Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitor
Catechol-O-Methyltransferase (COMT) Inhibitors
Others
In Chapter 7, on the basis of applications, the Parkinson’s Disease Drugs market from 2015 to 2025 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Parkinson’s Disease Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Parkinson’s Disease Drugs market covered in Chapter 13:
UCB S.A
Lundbeck A/S
Orion Pharma
Impax Laboratories, Inc.
Hoffmann-La Roche Ltd
Novartis AG
Pfizer, Inc.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc.
Vertical Pharmaceuticals, LLC
In Chapter 6, on the basis of types, the Parkinson’s Disease Drugs market from 2015 to 2025 is primarily split into:
Decarboxylase Inhibitors
Dopamine Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitor
Catechol-O-Methyltransferase (COMT) Inhibitors
Others
In Chapter 7, on the basis of applications, the Parkinson’s Disease Drugs market from 2015 to 2025 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 PARKINSON’S DISEASE DRUGS MARKET - RESEARCH SCOPE
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 PARKINSON’S DISEASE DRUGS MARKET - RESEARCH METHODOLOGY
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 PARKINSON’S DISEASE DRUGS MARKET FORCES
3.1 Global Parkinson’s Disease Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 PARKINSON’S DISEASE DRUGS MARKET - BY GEOGRAPHY
4.1 Global Parkinson’s Disease Drugs Market Value and Market Share by Regions
4.1.1 Global Parkinson’s Disease Drugs Value ($) by Region (2015-2020)
4.1.2 Global Parkinson’s Disease Drugs Value Market Share by Regions (2015-2020)
4.2 Global Parkinson’s Disease Drugs Market Production and Market Share by Major Countries
4.2.1 Global Parkinson’s Disease Drugs Production by Major Countries (2015-2020)
4.2.2 Global Parkinson’s Disease Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Parkinson’s Disease Drugs Market Consumption and Market Share by Regions
4.3.1 Global Parkinson’s Disease Drugs Consumption by Regions (2015-2020)
4.3.2 Global Parkinson’s Disease Drugs Consumption Market Share by Regions (2015-2020)
5 PARKINSON’S DISEASE DRUGS MARKET - BY TRADE STATISTICS
5.1 Global Parkinson’s Disease Drugs Export and Import
5.2 United States Parkinson’s Disease Drugs Export and Import (2015-2020)
5.3 Europe Parkinson’s Disease Drugs Export and Import (2015-2020)
5.4 China Parkinson’s Disease Drugs Export and Import (2015-2020)
5.5 Japan Parkinson’s Disease Drugs Export and Import (2015-2020)
5.6 India Parkinson’s Disease Drugs Export and Import (2015-2020)
5.7 ...
6 PARKINSON’S DISEASE DRUGS MARKET - BY TYPE
6.1 Global Parkinson’s Disease Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Parkinson’s Disease Drugs Production by Types (2015-2020)
6.1.2 Global Parkinson’s Disease Drugs Production Market Share by Types (2015-2020)
6.2 Global Parkinson’s Disease Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Parkinson’s Disease Drugs Value by Types (2015-2020)
6.2.2 Global Parkinson’s Disease Drugs Value Market Share by Types (2015-2020)
6.3 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Decarboxylase Inhibitors (2015-2020)
6.4 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Dopamine Agonists (2015-2020)
6.5 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2015-2020)
6.6 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2015-2020)
6.7 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Others (2015-2020)
7 PARKINSON’S DISEASE DRUGS MARKET - BY APPLICATION
7.1 Global Parkinson’s Disease Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Parkinson’s Disease Drugs Consumption by Applications (2015-2020)
7.1.2 Global Parkinson’s Disease Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Hospital Pharmacy (2015-2020)
7.3 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Retail Pharmacy (2015-2020)
7.4 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Online Pharmacy (2015-2020)
8 NORTH AMERICA PARKINSON’S DISEASE DRUGS MARKET
8.1 North America Parkinson’s Disease Drugs Market Size
8.2 United States Parkinson’s Disease Drugs Market Size
8.3 Canada Parkinson’s Disease Drugs Market Size
8.4 Mexico Parkinson’s Disease Drugs Market Size
8.5 The Influence of COVID-19 on North America Market
9 EUROPE PARKINSON’S DISEASE DRUGS MARKET ANALYSIS
9.1 Europe Parkinson’s Disease Drugs Market Size
9.2 Germany Parkinson’s Disease Drugs Market Size
9.3 United Kingdom Parkinson’s Disease Drugs Market Size
9.4 France Parkinson’s Disease Drugs Market Size
9.5 Italy Parkinson’s Disease Drugs Market Size
9.6 Spain Parkinson’s Disease Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market
10 ASIA-PACIFIC PARKINSON’S DISEASE DRUGS MARKET ANALYSIS
10.1 Asia-Pacific Parkinson’s Disease Drugs Market Size
10.2 China Parkinson’s Disease Drugs Market Size
10.3 Japan Parkinson’s Disease Drugs Market Size
10.4 South Korea Parkinson’s Disease Drugs Market Size
10.5 Southeast Asia Parkinson’s Disease Drugs Market Size
10.6 India Parkinson’s Disease Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 MIDDLE EAST AND AFRICA PARKINSON’S DISEASE DRUGS MARKET ANALYSIS
11.1 Middle East and Africa Parkinson’s Disease Drugs Market Size
11.2 Saudi Arabia Parkinson’s Disease Drugs Market Size
11.3 UAE Parkinson’s Disease Drugs Market Size
11.4 South Africa Parkinson’s Disease Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 SOUTH AMERICA PARKINSON’S DISEASE DRUGS MARKET ANALYSIS
12.1 South America Parkinson’s Disease Drugs Market Size
12.2 Brazil Parkinson’s Disease Drugs Market Size
12.3 The Influence of COVID-19 on South America Market
13 COMPANY PROFILES
13.1 UCB S.A
13.1.1 UCB S.A Basic Information
13.1.2 UCB S.A Product Profiles, Application and Specification
13.1.3 UCB S.A Parkinson’s Disease Drugs Market Performance (2015-2020)
13.2 Lundbeck A/S
13.2.1 Lundbeck A/S Basic Information
13.2.2 Lundbeck A/S Product Profiles, Application and Specification
13.2.3 Lundbeck A/S Parkinson’s Disease Drugs Market Performance (2015-2020)
13.3 Orion Pharma
13.3.1 Orion Pharma Basic Information
13.3.2 Orion Pharma Product Profiles, Application and Specification
13.3.3 Orion Pharma Parkinson’s Disease Drugs Market Performance (2015-2020)
13.4 Impax Laboratories, Inc.
13.4.1 Impax Laboratories, Inc. Basic Information
13.4.2 Impax Laboratories, Inc. Product Profiles, Application and Specification
13.4.3 Impax Laboratories, Inc. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.5 Hoffmann-La Roche Ltd
13.5.1 Hoffmann-La Roche Ltd Basic Information
13.5.2 Hoffmann-La Roche Ltd Product Profiles, Application and Specification
13.5.3 Hoffmann-La Roche Ltd Parkinson’s Disease Drugs Market Performance (2015-2020)
13.6 Novartis AG
13.6.1 Novartis AG Basic Information
13.6.2 Novartis AG Product Profiles, Application and Specification
13.6.3 Novartis AG Parkinson’s Disease Drugs Market Performance (2015-2020)
13.7 Pfizer, Inc.
13.7.1 Pfizer, Inc. Basic Information
13.7.2 Pfizer, Inc. Product Profiles, Application and Specification
13.7.3 Pfizer, Inc. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.8 Merck & Co., Inc.
13.8.1 Merck & Co., Inc. Basic Information
13.8.2 Merck & Co., Inc. Product Profiles, Application and Specification
13.8.3 Merck & Co., Inc. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.9 Teva Pharmaceutical Industries Ltd.
13.9.1 Teva Pharmaceutical Industries Ltd. Basic Information
13.9.2 Teva Pharmaceutical Industries Ltd. Product Profiles, Application and Specification
13.9.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.10 ACADIA Pharmaceuticals Inc.
13.10.1 ACADIA Pharmaceuticals Inc. Basic Information
13.10.2 ACADIA Pharmaceuticals Inc. Product Profiles, Application and Specification
13.10.3 ACADIA Pharmaceuticals Inc. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.11 Vertical Pharmaceuticals, LLC
13.11.1 Vertical Pharmaceuticals, LLC Basic Information
13.11.2 Vertical Pharmaceuticals, LLC Product Profiles, Application and Specification
13.11.3 Vertical Pharmaceuticals, LLC Parkinson’s Disease Drugs Market Performance (2015-2020)
14 MARKET FORECAST - BY REGIONS
14.1 North America Parkinson’s Disease Drugs Market Forecast (2020-2025)
14.2 Europe Parkinson’s Disease Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Parkinson’s Disease Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Parkinson’s Disease Drugs Market Forecast (2020-2025)
14.5 South America Parkinson’s Disease Drugs Market Forecast (2020-2025)
15 MARKET FORECAST - BY TYPE AND APPLICATIONS
15.1 Global Parkinson’s Disease Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Parkinson’s Disease Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Parkinson’s Disease Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Parkinson’s Disease Drugs Market Forecast by Applications (2020-2025)
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 PARKINSON’S DISEASE DRUGS MARKET - RESEARCH METHODOLOGY
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 PARKINSON’S DISEASE DRUGS MARKET FORCES
3.1 Global Parkinson’s Disease Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 PARKINSON’S DISEASE DRUGS MARKET - BY GEOGRAPHY
4.1 Global Parkinson’s Disease Drugs Market Value and Market Share by Regions
4.1.1 Global Parkinson’s Disease Drugs Value ($) by Region (2015-2020)
4.1.2 Global Parkinson’s Disease Drugs Value Market Share by Regions (2015-2020)
4.2 Global Parkinson’s Disease Drugs Market Production and Market Share by Major Countries
4.2.1 Global Parkinson’s Disease Drugs Production by Major Countries (2015-2020)
4.2.2 Global Parkinson’s Disease Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Parkinson’s Disease Drugs Market Consumption and Market Share by Regions
4.3.1 Global Parkinson’s Disease Drugs Consumption by Regions (2015-2020)
4.3.2 Global Parkinson’s Disease Drugs Consumption Market Share by Regions (2015-2020)
5 PARKINSON’S DISEASE DRUGS MARKET - BY TRADE STATISTICS
5.1 Global Parkinson’s Disease Drugs Export and Import
5.2 United States Parkinson’s Disease Drugs Export and Import (2015-2020)
5.3 Europe Parkinson’s Disease Drugs Export and Import (2015-2020)
5.4 China Parkinson’s Disease Drugs Export and Import (2015-2020)
5.5 Japan Parkinson’s Disease Drugs Export and Import (2015-2020)
5.6 India Parkinson’s Disease Drugs Export and Import (2015-2020)
5.7 ...
6 PARKINSON’S DISEASE DRUGS MARKET - BY TYPE
6.1 Global Parkinson’s Disease Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Parkinson’s Disease Drugs Production by Types (2015-2020)
6.1.2 Global Parkinson’s Disease Drugs Production Market Share by Types (2015-2020)
6.2 Global Parkinson’s Disease Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Parkinson’s Disease Drugs Value by Types (2015-2020)
6.2.2 Global Parkinson’s Disease Drugs Value Market Share by Types (2015-2020)
6.3 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Decarboxylase Inhibitors (2015-2020)
6.4 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Dopamine Agonists (2015-2020)
6.5 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2015-2020)
6.6 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2015-2020)
6.7 Global Parkinson’s Disease Drugs Production, Price and Growth Rate of Others (2015-2020)
7 PARKINSON’S DISEASE DRUGS MARKET - BY APPLICATION
7.1 Global Parkinson’s Disease Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Parkinson’s Disease Drugs Consumption by Applications (2015-2020)
7.1.2 Global Parkinson’s Disease Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Hospital Pharmacy (2015-2020)
7.3 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Retail Pharmacy (2015-2020)
7.4 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Online Pharmacy (2015-2020)
8 NORTH AMERICA PARKINSON’S DISEASE DRUGS MARKET
8.1 North America Parkinson’s Disease Drugs Market Size
8.2 United States Parkinson’s Disease Drugs Market Size
8.3 Canada Parkinson’s Disease Drugs Market Size
8.4 Mexico Parkinson’s Disease Drugs Market Size
8.5 The Influence of COVID-19 on North America Market
9 EUROPE PARKINSON’S DISEASE DRUGS MARKET ANALYSIS
9.1 Europe Parkinson’s Disease Drugs Market Size
9.2 Germany Parkinson’s Disease Drugs Market Size
9.3 United Kingdom Parkinson’s Disease Drugs Market Size
9.4 France Parkinson’s Disease Drugs Market Size
9.5 Italy Parkinson’s Disease Drugs Market Size
9.6 Spain Parkinson’s Disease Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market
10 ASIA-PACIFIC PARKINSON’S DISEASE DRUGS MARKET ANALYSIS
10.1 Asia-Pacific Parkinson’s Disease Drugs Market Size
10.2 China Parkinson’s Disease Drugs Market Size
10.3 Japan Parkinson’s Disease Drugs Market Size
10.4 South Korea Parkinson’s Disease Drugs Market Size
10.5 Southeast Asia Parkinson’s Disease Drugs Market Size
10.6 India Parkinson’s Disease Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 MIDDLE EAST AND AFRICA PARKINSON’S DISEASE DRUGS MARKET ANALYSIS
11.1 Middle East and Africa Parkinson’s Disease Drugs Market Size
11.2 Saudi Arabia Parkinson’s Disease Drugs Market Size
11.3 UAE Parkinson’s Disease Drugs Market Size
11.4 South Africa Parkinson’s Disease Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 SOUTH AMERICA PARKINSON’S DISEASE DRUGS MARKET ANALYSIS
12.1 South America Parkinson’s Disease Drugs Market Size
12.2 Brazil Parkinson’s Disease Drugs Market Size
12.3 The Influence of COVID-19 on South America Market
13 COMPANY PROFILES
13.1 UCB S.A
13.1.1 UCB S.A Basic Information
13.1.2 UCB S.A Product Profiles, Application and Specification
13.1.3 UCB S.A Parkinson’s Disease Drugs Market Performance (2015-2020)
13.2 Lundbeck A/S
13.2.1 Lundbeck A/S Basic Information
13.2.2 Lundbeck A/S Product Profiles, Application and Specification
13.2.3 Lundbeck A/S Parkinson’s Disease Drugs Market Performance (2015-2020)
13.3 Orion Pharma
13.3.1 Orion Pharma Basic Information
13.3.2 Orion Pharma Product Profiles, Application and Specification
13.3.3 Orion Pharma Parkinson’s Disease Drugs Market Performance (2015-2020)
13.4 Impax Laboratories, Inc.
13.4.1 Impax Laboratories, Inc. Basic Information
13.4.2 Impax Laboratories, Inc. Product Profiles, Application and Specification
13.4.3 Impax Laboratories, Inc. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.5 Hoffmann-La Roche Ltd
13.5.1 Hoffmann-La Roche Ltd Basic Information
13.5.2 Hoffmann-La Roche Ltd Product Profiles, Application and Specification
13.5.3 Hoffmann-La Roche Ltd Parkinson’s Disease Drugs Market Performance (2015-2020)
13.6 Novartis AG
13.6.1 Novartis AG Basic Information
13.6.2 Novartis AG Product Profiles, Application and Specification
13.6.3 Novartis AG Parkinson’s Disease Drugs Market Performance (2015-2020)
13.7 Pfizer, Inc.
13.7.1 Pfizer, Inc. Basic Information
13.7.2 Pfizer, Inc. Product Profiles, Application and Specification
13.7.3 Pfizer, Inc. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.8 Merck & Co., Inc.
13.8.1 Merck & Co., Inc. Basic Information
13.8.2 Merck & Co., Inc. Product Profiles, Application and Specification
13.8.3 Merck & Co., Inc. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.9 Teva Pharmaceutical Industries Ltd.
13.9.1 Teva Pharmaceutical Industries Ltd. Basic Information
13.9.2 Teva Pharmaceutical Industries Ltd. Product Profiles, Application and Specification
13.9.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.10 ACADIA Pharmaceuticals Inc.
13.10.1 ACADIA Pharmaceuticals Inc. Basic Information
13.10.2 ACADIA Pharmaceuticals Inc. Product Profiles, Application and Specification
13.10.3 ACADIA Pharmaceuticals Inc. Parkinson’s Disease Drugs Market Performance (2015-2020)
13.11 Vertical Pharmaceuticals, LLC
13.11.1 Vertical Pharmaceuticals, LLC Basic Information
13.11.2 Vertical Pharmaceuticals, LLC Product Profiles, Application and Specification
13.11.3 Vertical Pharmaceuticals, LLC Parkinson’s Disease Drugs Market Performance (2015-2020)
14 MARKET FORECAST - BY REGIONS
14.1 North America Parkinson’s Disease Drugs Market Forecast (2020-2025)
14.2 Europe Parkinson’s Disease Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Parkinson’s Disease Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Parkinson’s Disease Drugs Market Forecast (2020-2025)
14.5 South America Parkinson’s Disease Drugs Market Forecast (2020-2025)
15 MARKET FORECAST - BY TYPE AND APPLICATIONS
15.1 Global Parkinson’s Disease Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Parkinson’s Disease Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Parkinson’s Disease Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Parkinson’s Disease Drugs Market Forecast by Applications (2020-2025)
LIST OF TABLES AND FIGURES
Figure Parkinson’s Disease Drugs Picture
Table Parkinson’s Disease Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Parkinson’s Disease Drugs Value ($) and Growth Rate (2015-2020)
Table Global Parkinson’s Disease Drugs Value ($) by Countries (2015-2020)
Table Global Parkinson’s Disease Drugs Value Market Share by Regions (2015-2020)
Figure Global Parkinson’s Disease Drugs Value Market Share by Regions in 2019
Figure Global Parkinson’s Disease Drugs Production and Growth Rate (2015-2020)
Table Global Parkinson’s Disease Drugs Production by Major Countries (2015-2020)
Table Global Parkinson’s Disease Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Parkinson’s Disease Drugs Production Market Share by Regions in 2019
Figure Global Parkinson’s Disease Drugs Consumption and Growth Rate (2015-2020)
Table Global Parkinson’s Disease Drugs Consumption by Regions (2015-2020)
Table Global Parkinson’s Disease Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Parkinson’s Disease Drugs Consumption Market Share by Regions in 2019
Table Global Parkinson’s Disease Drugs Export Top 3 Country 2019
Table Global Parkinson’s Disease Drugs Import Top 3 Country 2019
Table United States Parkinson’s Disease Drugs Export and Import (2015-2020)
Table Europe Parkinson’s Disease Drugs Export and Import (2015-2020)
Table China Parkinson’s Disease Drugs Export and Import (2015-2020)
Table Japan Parkinson’s Disease Drugs Export and Import (2015-2020)
Table India Parkinson’s Disease Drugs Export and Import (2015-2020)
Table Global Parkinson’s Disease Drugs Production by Types (2015-2020)
Table Global Parkinson’s Disease Drugs Production Market Share by Types (2015-2020)
Figure Global Parkinson’s Disease Drugs Production Share by Type (2015-2020)
Table Global Parkinson’s Disease Drugs Value by Types (2015-2020)
Table Global Parkinson’s Disease Drugs Value Market Share by Types (2015-2020)
Figure Global Parkinson’s Disease Drugs Value Share by Type (2015-2020)
Figure Global Decarboxylase Inhibitors Production and Growth Rate (2015-2020)
Figure Global Decarboxylase Inhibitors Price (2015-2020)
Figure Global Dopamine Agonists Production and Growth Rate (2015-2020)
Figure Global Dopamine Agonists Price (2015-2020)
Figure Global Monoamine Oxidase Type B (MAO-B) Inhibitor Production and Growth Rate (2015-2020)
Figure Global Monoamine Oxidase Type B (MAO-B) Inhibitor Price (2015-2020)
Figure Global Catechol-O-Methyltransferase (COMT) Inhibitors Production and Growth Rate (2015-2020)
Figure Global Catechol-O-Methyltransferase (COMT) Inhibitors Price (2015-2020)
Figure Global Others Production and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Parkinson’s Disease Drugs Consumption by Applications (2015-2020)
Table Global Parkinson’s Disease Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Parkinson’s Disease Drugs Consumption Share by Application (2015-2020)
Figure Global Hospital Pharmacy Consumption and Growth Rate (2015-2020)
Figure Global Retail Pharmacy Consumption and Growth Rate (2015-2020)
Figure Global Online Pharmacy Consumption and Growth Rate (2015-2020)
Figure North America Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table North America Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table Europe Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure China Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table South America Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table UCB S.A Company Profile
Table UCB S.A Production, Value, Price, Gross Margin 2015-2020
Figure UCB S.A Production and Growth Rate
Figure UCB S.A Value ($) Market Share 2015-2020
Table Lundbeck A/S Company Profile
Table Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020
Figure Lundbeck A/S Production and Growth Rate
Figure Lundbeck A/S Value ($) Market Share 2015-2020
Table Orion Pharma Company Profile
Table Orion Pharma Production, Value, Price, Gross Margin 2015-2020
Figure Orion Pharma Production and Growth Rate
Figure Orion Pharma Value ($) Market Share 2015-2020
Table Impax Laboratories, Inc. Company Profile
Table Impax Laboratories, Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Impax Laboratories, Inc. Production and Growth Rate
Figure Impax Laboratories, Inc. Value ($) Market Share 2015-2020
Table Hoffmann-La Roche Ltd Company Profile
Table Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2015-2020
Figure Hoffmann-La Roche Ltd Production and Growth Rate
Figure Hoffmann-La Roche Ltd Value ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Production, Value, Price, Gross Margin 2015-2020
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Pfizer, Inc. Company Profile
Table Pfizer, Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Value ($) Market Share 2015-2020
Table Merck & Co., Inc. Company Profile
Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Merck & Co., Inc. Production and Growth Rate
Figure Merck & Co., Inc. Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2015-2020
Table ACADIA Pharmaceuticals Inc. Company Profile
Table ACADIA Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
Figure ACADIA Pharmaceuticals Inc. Production and Growth Rate
Figure ACADIA Pharmaceuticals Inc. Value ($) Market Share 2015-2020
Table Vertical Pharmaceuticals, LLC Company Profile
Table Vertical Pharmaceuticals, LLC Production, Value, Price, Gross Margin 2015-2020
Figure Vertical Pharmaceuticals, LLC Production and Growth Rate
Figure Vertical Pharmaceuticals, LLC Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Production by Types (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Consumption Share by Applications (2020-2025)
Figure Parkinson’s Disease Drugs Picture
Table Parkinson’s Disease Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Parkinson’s Disease Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Parkinson’s Disease Drugs Value ($) and Growth Rate (2015-2020)
Table Global Parkinson’s Disease Drugs Value ($) by Countries (2015-2020)
Table Global Parkinson’s Disease Drugs Value Market Share by Regions (2015-2020)
Figure Global Parkinson’s Disease Drugs Value Market Share by Regions in 2019
Figure Global Parkinson’s Disease Drugs Production and Growth Rate (2015-2020)
Table Global Parkinson’s Disease Drugs Production by Major Countries (2015-2020)
Table Global Parkinson’s Disease Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Parkinson’s Disease Drugs Production Market Share by Regions in 2019
Figure Global Parkinson’s Disease Drugs Consumption and Growth Rate (2015-2020)
Table Global Parkinson’s Disease Drugs Consumption by Regions (2015-2020)
Table Global Parkinson’s Disease Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Parkinson’s Disease Drugs Consumption Market Share by Regions in 2019
Table Global Parkinson’s Disease Drugs Export Top 3 Country 2019
Table Global Parkinson’s Disease Drugs Import Top 3 Country 2019
Table United States Parkinson’s Disease Drugs Export and Import (2015-2020)
Table Europe Parkinson’s Disease Drugs Export and Import (2015-2020)
Table China Parkinson’s Disease Drugs Export and Import (2015-2020)
Table Japan Parkinson’s Disease Drugs Export and Import (2015-2020)
Table India Parkinson’s Disease Drugs Export and Import (2015-2020)
Table Global Parkinson’s Disease Drugs Production by Types (2015-2020)
Table Global Parkinson’s Disease Drugs Production Market Share by Types (2015-2020)
Figure Global Parkinson’s Disease Drugs Production Share by Type (2015-2020)
Table Global Parkinson’s Disease Drugs Value by Types (2015-2020)
Table Global Parkinson’s Disease Drugs Value Market Share by Types (2015-2020)
Figure Global Parkinson’s Disease Drugs Value Share by Type (2015-2020)
Figure Global Decarboxylase Inhibitors Production and Growth Rate (2015-2020)
Figure Global Decarboxylase Inhibitors Price (2015-2020)
Figure Global Dopamine Agonists Production and Growth Rate (2015-2020)
Figure Global Dopamine Agonists Price (2015-2020)
Figure Global Monoamine Oxidase Type B (MAO-B) Inhibitor Production and Growth Rate (2015-2020)
Figure Global Monoamine Oxidase Type B (MAO-B) Inhibitor Price (2015-2020)
Figure Global Catechol-O-Methyltransferase (COMT) Inhibitors Production and Growth Rate (2015-2020)
Figure Global Catechol-O-Methyltransferase (COMT) Inhibitors Price (2015-2020)
Figure Global Others Production and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Parkinson’s Disease Drugs Consumption by Applications (2015-2020)
Table Global Parkinson’s Disease Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Parkinson’s Disease Drugs Consumption Share by Application (2015-2020)
Figure Global Hospital Pharmacy Consumption and Growth Rate (2015-2020)
Figure Global Retail Pharmacy Consumption and Growth Rate (2015-2020)
Figure Global Online Pharmacy Consumption and Growth Rate (2015-2020)
Figure North America Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table North America Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table Europe Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure China Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Parkinson’s Disease Drugs Consumption by Countries (2015-2020)
Table South America Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Parkinson’s Disease Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Parkinson’s Disease Drugs Market Consumption and Growth Rate (2015-2020)
Table UCB S.A Company Profile
Table UCB S.A Production, Value, Price, Gross Margin 2015-2020
Figure UCB S.A Production and Growth Rate
Figure UCB S.A Value ($) Market Share 2015-2020
Table Lundbeck A/S Company Profile
Table Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020
Figure Lundbeck A/S Production and Growth Rate
Figure Lundbeck A/S Value ($) Market Share 2015-2020
Table Orion Pharma Company Profile
Table Orion Pharma Production, Value, Price, Gross Margin 2015-2020
Figure Orion Pharma Production and Growth Rate
Figure Orion Pharma Value ($) Market Share 2015-2020
Table Impax Laboratories, Inc. Company Profile
Table Impax Laboratories, Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Impax Laboratories, Inc. Production and Growth Rate
Figure Impax Laboratories, Inc. Value ($) Market Share 2015-2020
Table Hoffmann-La Roche Ltd Company Profile
Table Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2015-2020
Figure Hoffmann-La Roche Ltd Production and Growth Rate
Figure Hoffmann-La Roche Ltd Value ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Production, Value, Price, Gross Margin 2015-2020
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Pfizer, Inc. Company Profile
Table Pfizer, Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Value ($) Market Share 2015-2020
Table Merck & Co., Inc. Company Profile
Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Merck & Co., Inc. Production and Growth Rate
Figure Merck & Co., Inc. Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2015-2020
Table ACADIA Pharmaceuticals Inc. Company Profile
Table ACADIA Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
Figure ACADIA Pharmaceuticals Inc. Production and Growth Rate
Figure ACADIA Pharmaceuticals Inc. Value ($) Market Share 2015-2020
Table Vertical Pharmaceuticals, LLC Company Profile
Table Vertical Pharmaceuticals, LLC Production, Value, Price, Gross Margin 2015-2020
Figure Vertical Pharmaceuticals, LLC Production and Growth Rate
Figure Vertical Pharmaceuticals, LLC Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Production by Types (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Parkinson’s Disease Drugs Market Forecast Consumption Share by Applications (2020-2025)
